You have 9 free searches left this month | for more free features.

Suspected Renal Cell Carcinoma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Clear Cell Renal Cell Carcinoma, Suspected Recurrent Renal Clear Cell Carcinoma, Recurrent Renal Cell Cancer Trial

Not yet recruiting
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • (no location specified)
May 14, 2023

Carcinoma, Renal Cell, Clear Cell Renal Cell Carcinoma Trial in Yokohama City (89Zr-girentuximab)

Completed
  • Carcinoma, Renal Cell
  • Clear Cell Renal Cell Carcinoma
  • 89Zr-girentuximab
  • Yokohama City, Kanagawa, Japan
    Yokohama City University Hospital
Aug 18, 2021

Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Boston (Implantable Microdevice (IMD))

Not yet recruiting
  • Renal Cell Carcinoma
  • +2 more
  • Implantable Microdevice (IMD)
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 17, 2023

Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

Not yet recruiting
  • Clear Cell Renal Cell Carcinoma
  • 68Ga-NY104 PET/CT
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
May 18, 2023

Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104)

Completed
  • Clear Cell Renal Cell Carcinoma
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Feb 6, 2023

Renal Cell Carcinoma Metastases to Pancreas

Completed
  • Surgery
    • (no location specified)
    May 21, 2023

    Delving Into Participation Trends in Renal Cell Carcinoma

    Not yet recruiting
    • Renal Cell Carcinoma
      • San Francisco, California
        Power Life Sciences
      Oct 16, 2023

      Moesin Expression in Clear Cell Renal Cell Carcinoma

      Completed
      • Renal Cell Carcinoma
      • Immunohistochemical detection of Moesin in Clear cell Renal Cell Carcinoma
      • (no location specified)
      Sep 20, 2023

      Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

      Recruiting
      • Renal Cell Carcinoma
      • 68Ga-NY104 PET/CT
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      Jun 5, 2023

      Renal Cell Carcinoma Trial (Sunitinib)

      Not yet recruiting
      • Renal Cell Carcinoma
      • (no location specified)
      Sep 11, 2023

      ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

      Not yet recruiting
      • ccRCC
      • +20 more
      • (no location specified)
      Jul 6, 2023

      Metastatic Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

      Not yet recruiting
      • Metastatic Clear Cell Renal Cell Carcinoma
      • 68Ga-NY104 PET/CT
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      May 18, 2023

      Clear Cell Renal Cell Carcinoma Trial in Los Angeles (89Zr-DFO-girentuximab)

      Available
      • Clear Cell Renal Cell Carcinoma
      • 89Zr-DFO-girentuximab
      • Los Angeles, California
        UCLA
      Oct 12, 2023

      Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

      Not yet recruiting
      • Clear Cell Renal Cell Carcinoma
      • 68Ga-NY104 PET/CT
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      May 28, 2023

      Clear Cell Renal Cell Carcinoma?Resistance to Immunotherapy Trial in Shanghai (AK104(anti-PD-1/CTLA-4 bi-specific antibody

      Recruiting
      • Clear Cell Renal Cell Carcinoma、Resistance to Immunotherapy
      • AK104(anti-PD-1/CTLA-4 bi-specific antibody ,intravenously),lenvatinib( targeted VEGFR 1-3、FGFR、PDGFRα, small molecule TKI,orally
      • Shanghai, Shanghai, China
        Shanghai Renji Hospital
      Sep 12, 2023

      Advanced Renal Cell Carcinoma Trial in Beijing (ST-1898 tablets)

      Recruiting
      • Advanced Renal Cell Carcinoma
      • ST-1898 tablets
      • Beijing, Beijing, China
        Peking University Cancer Hospital & Institute
      Nov 6, 2023

      Renal Cell Carcinoma Trial (HS-10516)

      Not yet recruiting
      • Renal Cell Carcinoma
      • (no location specified)
      Sep 24, 2023

      Renal Cell Carcinoma Trial in Birmingham (Pembrolizumab injection)

      Not yet recruiting
      • Renal Cell Carcinoma
      • Pembrolizumab injection
      • Birmingham, Alabama
        University of Alabama at Birmingham
      Aug 20, 2023

      Renal Cell Carcinoma Trial in Tabriz (Sodium Pentaborate)

      Not yet recruiting
      • Renal Cell Carcinoma
      • Sodium Pentaborate
      • Tabriz, East Azarbayejan, Iran, Islamic Republic of
        Imam Reza hospital and Clinic of Salamat
      Mar 23, 2023

      Von Hippel-Lindau: Clinical Manifestations, Diagnosis,

      Recruiting
      • Kidney Cancer
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 25, 2023

        Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)

        Not yet recruiting
        • Papillary Renal Cell Carcinoma
        • (no location specified)
        Nov 24, 2023

        Renal Cell Carcinoma Trial in Guangzhou (Pucotenlimab Combined With Lenvatinib)

        Not yet recruiting
        • Renal Cell Carcinoma
        • Pucotenlimab Combined With Lenvatinib
        • Guangzhou, Other (Non U.s.), China
          Sun Yat-sen University Cancer Center
        Nov 10, 2023

        Advanced Clear Cell Renal Carcinoma (Ccrcc), Papillary Renal Cell Carcinoma (Prcc) Trial run by the National Cancer Institute

        Not yet recruiting
        • Advanced Clear Cell Renal Carcinoma (Ccrcc)
        • Papillary Renal Cell Carcinoma (Prcc)
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Feb 2, 2023

        Renal Cell Carcinoma, First-line Treatment, Non Clear Cell Renal Cell Carcinoma Trial in Chengdu (AK104, Axitinib)

        Not yet recruiting
        • Renal Cell Carcinoma
        • +3 more
        • Chengdu, Sichuan, China
          West China Hospital
        Apr 10, 2023

        Clinical Factors on Prognosis of Papillary Renal Cell Carcinoma

        Completed
        • Carcinoma, Renal Cell
        • We do not have any interventions. This study is based on obseravation.
        • (no location specified)
        Oct 27, 2023